Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

2.20
+0.04001.85%
Pre-market: 2.290.0900+4.09%09:11 EDT
Volume:216.33K
Turnover:479.54K
Market Cap:5.22M
PE:-0.19
High:2.31
Open:2.19
Low:2.13
Close:2.16
Loading ...
May 09, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 08, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 28, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 10, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Major Issues Report

8-K - Current report
Mar 24, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Major Issues Report

8-K - Current report
Feb 01, 2023

Major Issues Report

8-K - Current report
Jan 31, 2023

Major Issues Report

8-K - Current report
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Correspondence

CORRESP [Cover] - Correspondence
Jan 13, 2023

Major Issues Report

8-K - Current report
Dec 27, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals